Katarzyna Kluzek

1.6k total citations · 1 hit paper
14 papers, 1.1k citations indexed

About

Katarzyna Kluzek is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Katarzyna Kluzek has authored 14 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Katarzyna Kluzek's work include DNA Repair Mechanisms (4 papers), Renal cell carcinoma treatment (4 papers) and interferon and immune responses (3 papers). Katarzyna Kluzek is often cited by papers focused on DNA Repair Mechanisms (4 papers), Renal cell carcinoma treatment (4 papers) and interferon and immune responses (3 papers). Katarzyna Kluzek collaborates with scholars based in Poland, Netherlands and Taiwan. Katarzyna Kluzek's co-authors include Małgorzata Z. Zdzienicka, Aneta Białkowska, Andrew Tutt, Alan Ashworth, Sally Swift, Sabrina Giavara, Nuala McCabe, Christopher J. Lord, Nicholas C. Turner and Graeme C.M. Smith and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and International Journal of Molecular Sciences.

In The Last Decade

Katarzyna Kluzek

14 papers receiving 1.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Deficiency in the Repair of DNA Damage by Homologous Recombination and Sensitivity to Poly(ADP-Ribose) Polymerase Inhibition

2006 977 citations Nuala McCabe, Nicholas C. Turner et al. Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Katarzyna Kluzek Poland	8	819	811	197	184	143	14	1.1k
Ioannis Assiotis United Kingdom	12	699 0.9×	1.0k 1.2×	274 1.4×	244 1.3×	198 1.4×	14	1.4k
Emily Villegas United States	3	766 0.9×	795 1.0×	251 1.3×	243 1.3×	66 0.5×	3	1.1k
Ana M. Mendes‐Pereira United Kingdom	8	559 0.7×	737 0.9×	151 0.8×	153 0.8×	101 0.7×	10	973
Farah Rehman United Kingdom	12	734 0.9×	743 0.9×	169 0.9×	110 0.6×	142 1.0×	22	1.1k
Niklas Loman Sweden	2	1.0k 1.3×	774 1.0×	463 2.4×	323 1.8×	238 1.7×	5	1.3k
Christian Bowman-Colin United States	11	541 0.7×	833 1.0×	234 1.2×	231 1.3×	80 0.6×	13	1.1k
Kaitlyn Wurz United States	7	823 1.0×	854 1.1×	294 1.5×	316 1.7×	60 0.4×	7	1.2k
John Stone United Kingdom	3	628 0.8×	427 0.5×	217 1.1×	110 0.6×	53 0.4×	5	780
Yang Peng United States	12	789 1.0×	906 1.1×	93 0.5×	216 1.2×	146 1.0×	27	1.4k
Kaiming Sun United States	9	685 0.8×	448 0.6×	98 0.5×	78 0.4×	105 0.7×	20	1.1k

Countries citing papers authored by Katarzyna Kluzek

Since Specialization

Citations

This map shows the geographic impact of Katarzyna Kluzek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katarzyna Kluzek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katarzyna Kluzek more than expected).

Fields of papers citing papers by Katarzyna Kluzek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katarzyna Kluzek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katarzyna Kluzek. The network helps show where Katarzyna Kluzek may publish in the future.

Co-authorship network of co-authors of Katarzyna Kluzek

This figure shows the co-authorship network connecting the top 25 collaborators of Katarzyna Kluzek. A scholar is included among the top collaborators of Katarzyna Kluzek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katarzyna Kluzek. Katarzyna Kluzek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Kluzek, Katarzyna, Mahdi Eskandarian Boroujeni, Bart Krist, et al.. (2025). Identification of ALEKSIN as a novel multi-IRF inhibitor of IRF- and STAT-mediated transcription in vascular inflammation and atherosclerosis. Frontiers in Pharmacology. 15. 1471182–1471182. 3 indexed citations

Boroujeni, Mahdi Eskandarian, et al.. (2025). Integrative multi-omics analysis of IFNγ-induced macrophages and atherosclerotic plaques reveals macrophage-dependent STAT1-driven transcription in atherosclerosis. Frontiers in Immunology. 16. 1590953–1590953. 1 indexed citations

Nowicka, Hanna, Katarzyna Błaszczyk, Katarzyna Kluzek, et al.. (2023). ISGF3 and STAT2/IRF9 Control Basal and IFN-Induced Transcription through Genome-Wide Binding of Phosphorylated and Unphosphorylated Complexes to Common ISRE-Containing ISGs. International Journal of Molecular Sciences. 24(24). 17635–17635. 9 indexed citations

Kluzek, Katarzyna, Mahdi Eskandarian Boroujeni, Shota Yamauchi, et al.. (2023). Time-dependent recruitment of GAF, ISGF3 and IRF1 complexes shapes IFNα and IFNγ-activated transcriptional responses and explains mechanistic and functional overlap. Cellular and Molecular Life Sciences. 80(7). 187–187. 15 indexed citations

Wesoły, Joanna, Hanna Nowicka, Katarzyna Kluzek, et al.. (2023). Structural, topological, and functional characterization of transmembrane proteins TMEM213, 207, 116, 72 and 30B provides a potential link to ccRCC etiology.. PubMed. 13(5). 1863–1883. 5 indexed citations

Boroujeni, Mahdi Eskandarian, et al.. (2022). Dysregulated Interferon Response and Immune Hyperactivation in Severe COVID-19: Targeting STATs as a Novel Therapeutic Strategy. Frontiers in Immunology. 13. 888897–888897. 37 indexed citations

Kluzek, Katarzyna, et al.. (2021). Identification of RCC Subtype-Specific microRNAs–Meta-Analysis of High-Throughput RCC Tumor microRNA Expression Data. Cancers. 13(3). 548–548. 21 indexed citations

Kluzek, Katarzyna, et al.. (2017). Distinct cellular phenotype linked to defective DNA interstrand crosslink repair and homologous recombination. Molecular Medicine Reports. 16(2). 1885–1899. 1 indexed citations

Kluzek, Katarzyna, Malgorzata I. Srebniak, Kinga Humińska‐Lisowska, et al.. (2017). Genetic characterization of Polish ccRCC patients: somatic mutation analysis of PBRM1, BAP1 and KDMC5, genomic SNP array analysis in tumor biopsy and preliminary results of chromosome aberrations analysis in plasma cell free DNA. Oncotarget. 8(17). 28558–28574. 9 indexed citations

10.

Kluzek, Katarzyna, et al.. (2015). Potential Approaches and Recent Advances in Biomarker Discovery in Clear-Cell Renal Cell Carcinoma. Journal of Cancer. 6(11). 1105–1113. 32 indexed citations

11.

Kluzek, Katarzyna, Hans A.R. Bluyssen, & Joanna Wesoły. (2015). The epigenetic landscape of clear-cell renal cell carcinoma. SHILAP Revista de lepidopterología. 2(3). 90–104. 6 indexed citations

12.

Białkowska, Aneta, et al.. (2014). The role of the Fanconi anemia pathway in DNA repair and maintenance of genome stability. Postępy Higieny i Medycyny Doświadczalnej. 68. 459–472. 2 indexed citations

13.

Kluzek, Katarzyna, et al.. (2012). Poly(ADP-ribose) polymerase (PARP) inhibitors in BRCA1/2 cancer therapy. Postępy Higieny i Medycyny Doświadczalnej. 66. 372–384. 7 indexed citations

14.

McCabe, Nuala, Nicholas C. Turner, Christopher J. Lord, et al.. (2006). Deficiency in the Repair of DNA Damage by Homologous Recombination and Sensitivity to Poly(ADP-Ribose) Polymerase Inhibition. Cancer Research. 66(16). 8109–8115. 977 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact